South Korea · Delayed Price · Currency is KRW Narae Nanotech Statistics
Total Valuation
Narae Nanotech has a market cap or net worth of KRW 69.08 billion. The enterprise value is 14.89 billion.
| Market Cap | 69.08B |
| Enterprise Value | 14.89B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Narae Nanotech has 10.61 million shares outstanding. The number of shares has decreased by -0.64% in one year.
| Current Share Class | 10.61M |
| Shares Outstanding | 10.61M |
| Shares Change (YoY) | -0.64% |
| Shares Change (QoQ) | -2.43% |
| Owned by Insiders (%) | 51.22% |
| Owned by Institutions (%) | n/a |
| Float | 5.14M |
Valuation Ratios
The trailing PE ratio is 1.12.
| PE Ratio | 1.12 |
| Forward PE | n/a |
| PS Ratio | 1.08 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | 5.51 |
| P/OCF Ratio | 4.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.14, with an EV/FCF ratio of 1.19.
| EV / Earnings | 0.23 |
| EV / Sales | 0.23 |
| EV / EBITDA | 2.14 |
| EV / EBIT | 8.25 |
| EV / FCF | 1.19 |
Financial Position
The company has a current ratio of 4.84, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.84 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.01 |
| Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is 64.87% and return on invested capital (ROIC) is 1.93%.
| Return on Equity (ROE) | 64.87% |
| Return on Assets (ROA) | 0.75% |
| Return on Invested Capital (ROIC) | 1.93% |
| Return on Capital Employed (ROCE) | 1.37% |
| Weighted Average Cost of Capital (WACC) | 9.37% |
| Revenue Per Employee | 399.52M |
| Profits Per Employee | 401.10M |
| Employee Count | 160 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Narae Nanotech has paid 16.57 billion in taxes.
| Income Tax | 16.57B |
| Effective Tax Rate | 20.52% |
Stock Price Statistics
The stock price has increased by +98.78% in the last 52 weeks. The beta is 0.61, so Narae Nanotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +98.78% |
| 50-Day Moving Average | 5,822.20 |
| 200-Day Moving Average | 4,905.40 |
| Relative Strength Index (RSI) | 58.77 |
| Average Volume (20 Days) | 29,802 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Narae Nanotech had revenue of KRW 63.92 billion and earned 64.18 billion in profits. Earnings per share was 5,838.28.
| Revenue | 63.92B |
| Gross Profit | 15.25B |
| Operating Income | 1.80B |
| Pretax Income | 80.74B |
| Net Income | 64.18B |
| EBITDA | 6.94B |
| EBIT | 1.80B |
| Earnings Per Share (EPS) | 5,838.28 |
Balance Sheet
The company has 54.33 billion in cash and 144.30 million in debt, with a net cash position of 54.18 billion or 5,106.50 per share.
| Cash & Cash Equivalents | 54.33B |
| Total Debt | 144.30M |
| Net Cash | 54.18B |
| Net Cash Per Share | 5,106.50 |
| Equity (Book Value) | 129.77B |
| Book Value Per Share | 12,229.47 |
| Working Capital | 70.28B |
Cash Flow
In the last 12 months, operating cash flow was 13.88 billion and capital expenditures -1.34 billion, giving a free cash flow of 12.54 billion.
| Operating Cash Flow | 13.88B |
| Capital Expenditures | -1.34B |
| Depreciation & Amortization | 5.14B |
| Net Borrowing | -69.42B |
| Free Cash Flow | 12.54B |
| FCF Per Share | 1,181.55 |
Margins
Gross margin is 23.85%, with operating and profit margins of 2.82% and 100.39%.
| Gross Margin | 23.85% |
| Operating Margin | 2.82% |
| Pretax Margin | 126.31% |
| Profit Margin | 100.39% |
| EBITDA Margin | 10.86% |
| EBIT Margin | 2.82% |
| FCF Margin | 19.61% |
Dividends & Yields
Narae Nanotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.64% |
| Shareholder Yield | 0.64% |
| Earnings Yield | 92.90% |
| FCF Yield | 18.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Narae Nanotech has an Altman Z-Score of 3.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | 6 |